(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe...
Stats | |
---|---|
本日の出来高 | 201 691 |
平均出来高 | 335 849 |
時価総額 | 11.42B |
EPS | $0 ( 2024-02-14 ) |
Last Dividend | $0.170 ( 2023-09-06 ) |
Next Dividend | $0 ( N/A ) |
P/E | 163.25 |
ATR14 | $0.0930 (0.08%) |
ボリューム 相関
Pro Medicus Ltd 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Pro Medicus Ltd 相関 - 通貨/商品
Pro Medicus Ltd 財務諸表
Annual | 2023 |
収益: | $124.90M |
総利益: | $92.37M (73.95 %) |
EPS: | $0.580 |
FY | 2023 |
収益: | $124.90M |
総利益: | $92.37M (73.95 %) |
EPS: | $0.580 |
FY | 2022 |
収益: | $93.46M |
総利益: | $70.28M (75.20 %) |
EPS: | $0.430 |
FY | 2021 |
収益: | $67.84M |
総利益: | $67.35M (99.28 %) |
EPS: | $0.297 |
Financial Reports:
No articles found.
Pro Medicus Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.120 (N/A) |
$0 (N/A) |
$0.130 (N/A) |
$0 (N/A) |
$0.170 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0100 | 2001-03-16 |
Last Dividend | $0.170 | 2023-09-06 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 45 | -- |
Total Paid Out | $1.503 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.27 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.13 | |
Div. Directional Score | 9.40 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
FID.AX | Ex Dividend Knight | 2023-08-25 | Semi-Annually | 0 | 0.00% | |
PPC.AX | Ex Dividend Knight | 2023-09-08 | Semi-Annually | 0 | 0.00% | |
ASG.AX | Ex Dividend Junior | 2023-10-31 | Annually | 0 | 0.00% | |
IFT.AX | Ex Dividend Knight | 2023-05-29 | Semi-Annually | 0 | 0.00% | |
SEK.AX | Ex Dividend Knight | 2023-09-06 | Annually | 0 | 0.00% | |
CD1.AX | Ex Dividend Junior | 2023-08-17 | Semi-Annually | 0 | 0.00% | |
MEC.AX | Ex Dividend Junior | 2023-08-25 | Semi-Annually | 0 | 0.00% | |
TLS.AX | Ex Dividend Knight | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
CWP.AX | Ex Dividend Junior | 2023-09-27 | Semi-Annually | 0 | 0.00% | |
NSC.AX | Ex Dividend Knight | 2023-09-06 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.490 | 1.500 | 0.190 | 0.285 | [0 - 0.5] |
returnOnAssetsTTM | 0.326 | 1.200 | 10.00 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.468 | 1.500 | 5.91 | 8.87 | [0.1 - 1] |
payoutRatioTTM | 0.449 | -1.000 | 5.51 | -5.51 | [0 - 1] |
currentRatioTTM | 7.49 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 7.45 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 4.25 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00721 | -1.500 | 9.88 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.721 | 2.00 | 9.76 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.658 | 2.00 | 9.67 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00970 | -1.500 | 9.96 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.741 | 1.000 | 0.982 | 0.982 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.673 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 48.73 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.664 | 0.800 | 8.91 | 7.13 | [0.5 - 2] |
Total Score | 11.67 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 163.86 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.468 | 2.50 | 7.37 | 8.87 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.658 | 2.00 | 9.78 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.320 | 1.500 | 2.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.721 | 2.00 | 9.76 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.449 | 1.500 | 5.51 | -5.51 | [0 - 1] |
pegRatioTTM | 3.78 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.530 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 7.13 |
Pro Medicus Ltd
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。